|
시장보고서
상품코드
1462958
마이크로바이옴 진단 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 샘플별, 제품별, 기술별, 용도별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)Microbiome Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample (Skin, Fecal, Saliva); By Product; By Technology; By Application; By End-User; By Region; Segment Forecast, 2024 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 마이크로바이옴 진단 세계 시장 규모는 2032년까지 4억 8,375만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
맞춤형 의료에 대한 수요 증가, 질병 발생률 증가, 마이크로바이옴 연구를 위한 학계와 마이크로바이옴 산업계의 협력적 노력은 마이크로바이옴 기반 진단 의약품 시장을 견인하고 있습니다. 마이크로바이옴 진단 시장은 신흥국의 확대와 새로운 마이크로바이옴 기술 개발에 대한 업계 기업들의 협력 증가로 인해 수익성 높은 성장이 예상됩니다.
마이크로바이옴의 상업화는 다양한 규제 정책과 가이드라인의 영향을 받는 다면적인 과정입니다. 이러한 규제는 마이크로바이옴 기반 제품 및 서비스의 안전성과 유효성을 보장하기 위해 마련되었습니다. 그러나 이러한 규제는 마이크로바이옴 기반 진단 시장의 상업화와 성장에 큰 걸림돌이 되기도 합니다. 규제 요건은 엄격한 테스트, 문서화 및 승인 절차를 요구하는 경우가 많으며, 이는 마이크로바이옴 기반 제품을 시장에 출시하려는 기업에게 시간과 비용이 많이 소요됩니다.
또한, 마이크로바이옴 과학은 계속 진화하고 있기 때문에 규제 프레임워크가 아직 개발 중이거나 변경될 가능성이 있어 상용화 과정을 더욱 복잡하게 만들고 있습니다. 이러한 어려움에도 불구하고, 소비자 안전을 보장하고 시장에서 마이크로바이옴 기반 제품 및 서비스의 신뢰성을 유지하기 위해서는 규제 표준을 준수하는 것이 필수적입니다.
미생물체 연구 분야는 빠르게 성장하고 있는 분야로, 수많은 소규모의 혁신적 기업들이 주요 이해관계자들에게 높은 성장 기회를 제공합니다. 당뇨병, 간질환, 비만, 대사성 질환 등 다양한 질병에 대한 진단 키트와 바이오마커 표적 발굴을 중심으로 마이크로바이옴 연구를 위한 기업 인수에 대한 이해관계자들의 관심이 높아지고 있습니다. 시장 개척의 선두주자들은 제품 파이프라인을 강화하기 위해 전략적 제휴와 파트너십을 중시하며 체계적인 연구개발 전략을 채택하고 있습니다. 지난 2년 동안 주요 기업 간의 공동 연구와 제휴가 눈에 띄게 증가했으며, 이는 헬스케어 및 기타 분야에서 마이크로바이옴 연구의 중요성과 잠재력이 증가하고 있음을 반영합니다.
마이크로바이옴 진단 시장 보고서 하이라이트
마이크로바이옴 샘플의 정확하고 정밀한 분석을 가능하게 함으로써 마이크로바이옴 진단에 중요한 역할을 하는 기기 부문이 2023년 시장을 주도할 것으로 예상됩니다.
제약 및 생명공학 기업들은 마이크로바이옴 데이터를 활용하여 혁신적인 치료법, 개인 맞춤형 의료 및 첨단 프로바이오틱스 개발을 주요 목표로 삼고 있기 때문에 2023년에도 시장을 선도하고 우위를 유지할 것으로 예상됩니다.
북미지역은 전 세계 마이크로바이옴 진단 시장에서 큰 비중을 차지하고 있으며, 이는 미국과 캐나다의 연구개발(R&D) 노력에 힘입어 큰 폭으로 성장하고 있기 때문입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 마이크로바이옴 진단 시장 인사이트
- 마이크로바이옴 진단 - 업계 현황
- 마이크로바이옴 진단 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTLE 분석
- 마이크로바이옴 진단 업계 동향
- COVID-19의 영향 분석
제5장 샘플별 세계 시장
- 주요 조사 결과
- 서론
- 피부
- 분변
- 타액
- 기타
제6장 제품별 세계 시장
- 주요 조사 결과
- 서론
- 기기
- 시약 및 키트
제7장 기술별 세계 시장
- 주요 조사 결과
- 서론
- Metatranscriptomics
- Shot Gun Metagenomic
- 16s rRNA Sequencing
제8장 용도별 세계 시장
- 주요 조사 결과
- 서론
- 연구 용도
- 질병 진단 용도
제9장 최종사용자별 세계 시장
- 주요 조사 결과
- 서론
- 학술연구기관
- 병원
- 제약 기업 및 바이오테크놀러지 기업
제10장 지역별 세계 시장
- 주요 조사 결과
- 서론
- 마이크로바이옴 진단 시장 평가, 지역별, 2019-2032년
- 마이크로바이옴 진단 시장 - 북미
- 북미 : 마이크로바이옴 진단 시장, 샘플별, 2019년-2032년
- 북미 : 마이크로바이옴 진단 시장, 용도별, 2019년-2032년
- 북미 : 마이크로바이옴 진단 시장, 제품별, 2019년-2032년
- 북미 : 마이크로바이옴 진단 시장, 기술별, 2019년-2032년
- 북미 : 마이크로바이옴 진단 시장, 최종사용자별, 2019년-2032년
- 마이크로바이옴 진단 시장 - 미국
- 마이크로바이옴 진단 시장 - 캐나다
- 마이크로바이옴 진단 시장 - 유럽
- 유럽 : 마이크로바이옴 진단 시장, 샘플별, 2019-2032년
- 유럽 : 마이크로바이옴 진단 시장, 용도별, 2019-2032년
- 유럽 : 마이크로바이옴 진단 시장, 제품별, 2019년-2032년
- 유럽 : 마이크로바이옴 진단 시장, 기술별, 2019-2032년
- 유럽 : 마이크로바이옴 진단 시장, 최종사용자별, 2019년-2032년
- 마이크로바이옴 진단 시장 - 영국
- 마이크로바이옴 진단 시장 - 프랑스
- 마이크로바이옴 진단 시장 - 독일
- 마이크로바이옴 진단 시장 - 이탈리아
- 마이크로바이옴 진단 시장 - 스페인
- 마이크로바이옴 진단 시장 - 네덜란드
- 마이크로바이옴 진단 시장 - 러시아
- 마이크로바이옴 진단 시장 - 아시아태평양
- 아시아태평양 : 마이크로바이옴 진단 시장, 샘플별, 2019년-2032년
- 아시아태평양 : 마이크로바이옴 진단 시장, 용도별, 2019년-2032년
- 아시아태평양 : 마이크로바이옴 진단 시장, 제품별, 2019년-2032년
- 아시아태평양 : 마이크로바이옴 진단 시장, 기술별, 2019년-2032년
- 아시아태평양 : 마이크로바이옴 진단 시장, 최종사용자별, 2019년-2032년
- 마이크로바이옴 진단 시장 - 중국
- 마이크로바이옴 진단 시장 - 인도
- 마이크로바이옴 진단 시장 - 일본
- 마이크로바이옴 진단 시장 - 말레이시아
- 마이크로바이옴 진단 시장 - 인도네시아
- 마이크로바이옴 진단 시장 - 한국
- 마이크로바이옴 진단 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 마이크로바이옴 진단 시장, 샘플별, 2019-2032년
- 중동 및 아프리카 : 마이크로바이옴 진단 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : 마이크로바이옴 진단 시장, 제품별, 2019-2032년
- 중동 및 아프리카 : 마이크로바이옴 진단 시장, 기술별, 2019-2032년
- 중동 및 아프리카 : 마이크로바이옴 진단 시장, 최종사용자별, 2019-2032년
- 마이크로바이옴 진단 시장 - 사우디아라비아
- 마이크로바이옴 진단 시장 - UAE
- 마이크로바이옴 진단 시장 - 이스라엘
- 마이크로바이옴 진단 시장 - 남아프리카
- 마이크로바이옴 진단 시장 - 라틴아메리카
- 라틴아메리카 : 마이크로바이옴 진단 시장, 샘플별, 2019년-2032년
- 라틴아메리카 : 마이크로바이옴 진단 시장, 용도별, 2019-2032년
- 라틴아메리카 : 마이크로바이옴 진단 시장, 제품별, 2019-2032년
- 라틴아메리카 : 마이크로바이옴 진단 시장, 기술별, 2019년-2032년
- 라틴아메리카 : 마이크로바이옴 진단 시장, 최종사용자별, 2019년-2032년
- 마이크로바이옴 진단 시장 - 멕시코
- 마이크로바이옴 진단 시장 - 브라질
- 마이크로바이옴 진단 시장 - 아르헨티나
제11장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 파트너십/협업/계약/공개
제12장 기업 개요
- DNA Genotek
- Genetic Analysis AS
- Microba
- 4D Pharma PLC
- AOBiome Therapeutics
- Atlas Biomed
- BioGaia
- BIOHM Health
- Bione Ventures Private Limited
- DayTwo
- Enterome
- Evvy
- Ferring Pharmaceuticals
- Finch Therapeutics Group
- Flightpath Biosciences, Inc
The global microbiome diagnostics market size is expected to reach USD 483.75 million by 2032, according to a new study by Polaris Market Research. The report "Microbiome Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample (Skin, Fecal, Saliva); By Product; By Technology; By Application; By End-User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising need for personalized medicine, increased illness incidence, and cooperative efforts between academia and the microbiome industry for microbiome research are pushing the market for microbiome-based diagnostics. The microbiome diagnostics market is expected to see profitable growth prospects due to the expansion of emerging nations and the growing cooperation of industry players on the development of novel microbiome technologies.
The commercialization of microbiomes is a multifaceted process influenced by a variety of regulatory policies and guidelines. These regulations are put in place to guarantee the safety and effectiveness of microbiome-based products and services. Still, they can also pose significant hurdles to commercialization and growth in the microbiome-based diagnostics market. Regulatory requirements often demand rigorous testing, documentation, and approval processes, which can be time-consuming and costly for companies seeking to bring microbiome-based products to market.
Additionally, the evolving nature of microbiome science means that regulatory frameworks may still be in development or subject to change, further complicating the commercialization process. Despite these challenges, adherence to regulatory standards is crucial for ensuring consumer safety and maintaining the credibility of microbiome-based products and services in the market.
In the rapidly expanding field of microbiome research, numerous small, innovative companies are creating high-growth opportunities for key stakeholders. There is a growing interest among stakeholders to acquire companies for microbiome research, with a focus on identifying diagnostic kits and biomarker targets for various conditions such as diabetes, liver disorders, obesity, and metabolic disorders. Market leaders are emphasizing strategic collaborations and partnerships to strengthen their product pipelines, employing organized research and development strategies. Over the past two years, there has been a noticeable increase in collaborations and partnerships involving major companies, reflecting the growing importance and potential of microbiome research in healthcare and beyond.
Microbiome Diagnostics Market Report Highlights
The instrument segment dominated the market in 2023, driven by its critical role in microbiome diagnostics by enabling the accurate and precise analysis of microbiome samples.
The pharmaceutical & biotechnology companies segment led the market in 2023 and is expected to maintain its dominance due to their primary goal being to utilize microbiome data to create innovative therapies, personalized medicine, and advanced probiotics.
North America holds a significant revenue share in the global Microbiome Diagnostics market, driven by undergoing substantial growth, largely fueled by heightened research and development endeavors in the United States and Canada.
The global key market players include DNA Genotek, Genetic Analysis AS, Microba, 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, Enterome, and Evvy,
Polaris Market Research has segmented the Microbiome Diagnostics market report based on sample, product, technology, application, end-user, and region:
Microbiome Diagnostics, Sample Outlook (Revenue - USD Million, 2019 - 2032)
- Skin
- Fecal
- Saliva
- Others
Microbiome Diagnostics, Product Outlook (Revenue - USD Million, 2019 - 2032)
- Instruments
- Reagents & Kits
Microbiome Diagnostics, Technology Outlook (Revenue - USD Million, 2019 - 2032)
- Metatranscriptomics
- Shot Gun Metagenomics
- 16s rRNA Sequencing
Microbiome Diagnostics, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Research Application
- Disease Diagnostics Application
- Metabolic Diseases
- Gastrointestinal Disorders
- Others
Microbiome Diagnostics, End-User Outlook (Revenue - USD Million, 2019 - 2032)
- Academic & Research Institutes
- Hospitals
- Pharmaceutical & Biotechnology Companies
Microbiome Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Microbiome Diagnostics Market Insights
- 4.1. Microbiome Diagnostics - Industry Snapshot
- 4.2. Microbiome Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Shift Towards Personalized Medicine
- 4.2.1.2. A rising number of partnerships between academic and microbiome institutes is projected to spur product demand
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Financing problems from end-users are likely to impede the market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Microbiome Diagnostics Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global Microbiome Diagnostics Market, by Sample
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 5.3. Skin
- 5.3.1. Global Microbiome Diagnostics Market, by Skin, by Region, 2019-2032 (USD Million)
- 5.4. Fecal
- 5.4.1. Global Microbiome Diagnostics Market, by Fecal, by Region, 2019-2032 (USD Million)
- 5.5. Saliva
- 5.5.1. Global Microbiome Diagnostics Market, by Saliva, by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Microbiome Diagnostics Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 6.3. Instruments
- 6.3.1. Global Microbiome Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
- 6.4. Reagents & Kits
- 6.4.1. Global Microbiome Diagnostics Market, by Reagents & Kits, by Region, 2019-2032 (USD Million)
7. Global Microbiome Diagnostics Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 7.3. Metatranscriptomics
- 7.3.1. Global Microbiome Diagnostics Market, by Metatranscriptomics, by Region, 2019-2032 (USD Million)
- 7.4. Shot Gun Metagenomics
- 7.4.1. Global Microbiome Diagnostics Market, by Shot Gun Metagenomics, by Region, 2019-2032 (USD Million)
- 7.4. 16s rRNA Sequencing
- 7.4.1. Global Microbiome Diagnostics Market, by 16s rRNA Sequencing, by Region, 2019-2032 (USD Million)
8. Global Microbiome Diagnostics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 8.3. Research Application
- 8.3.1. Global Microbiome Diagnostics Market, by Research Application, by Region, 2019-2032 (USD Million)
- 8.4. Disease Diagnostics Application
- 8.4.1. Global Microbiome Diagnostics Market, by Disease Diagnostics Application, by Region, 2019-2032 (USD Million)
- 8.4.2. Metabolic Diseases
- 8.4.2.1. Global Microbiome Diagnostics Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
- 8.4.3. Gastrointestinal Disorders
- 8.4.3.1. Global Microbiome Diagnostics Market, by Gastrointestinal Disorders, by Region, 2019-2032 (USD Million)
- 8.4.4. Others
- 8.4.4.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)
9. Global Microbiome Diagnostics Market, by End-User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 9.3. Academic & Research Institutes
- 9.3.1. Global Microbiome Diagnostics Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
- 9.4. Hospitals
- 9.4.1. Global Microbiome Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Million)
- 9.5. Pharmaceutical & Biotechnology Companies
- 9.5.1. Global Microbiome Diagnostics Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
10. Global Microbiome Diagnostics Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. Microbiome Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
- 10.3. Microbiome Diagnostics Market - North America
- 10.3.1. North America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.3.2. North America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.3.3. North America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.3.4. North America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.3.5. North America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.3.6. Microbiome Diagnostics Market - U.S.
- 10.3.6.1. U.S.: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.3.6.2. U.S.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.3.6.3. U.S.: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.3.6.4. U.S.: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.3.6.5. U.S.: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.3.7. Microbiome Diagnostics Market - Canada
- 10.3.7.1. Canada: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.3.7.2. Canada.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.3.7.3. Canada: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.3.7.4. Canada: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.3.7.5. Canada: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4. Microbiome Diagnostics Market - Europe
- 10.4.1. Europe: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.2. Europe.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.3. Europe: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.4. Europe: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.5. Europe: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.6. Microbiome Diagnostics Market - UK
- 10.4.6.1. UK: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.6.2. UK.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.6.3. UK: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.6.4. UK: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.6.5. UK: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.7. Microbiome Diagnostics Market - France
- 10.4.7.1. France: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.7.2. France.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.7.3. France: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.7.4. France: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.7.5. France: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.8. Microbiome Diagnostics Market - Germany
- 10.4.8.1. Germany: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.8.2. Germany.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.8.3. Germany: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.8.4. Germany: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.8.5. Germany: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.9. Microbiome Diagnostics Market - Italy
- 10.4.9.1. Italy: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.9.2. Italy.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.9.3. Italy: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.9.4. Italy: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.9.5. Italy: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.10. Microbiome Diagnostics Market - Spain
- 10.4.10.1. Spain: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.10.2. Spain.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.10.3. Spain: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.10.4. Spain: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.10.5. Spain: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.11. Microbiome Diagnostics Market - Netherlands
- 10.4.11.1. Netherlands: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.11.2. Netherlands.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.11.3. Netherlands: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.11.4. Netherlands: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.11.5. Netherlands: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.4.12. Microbiome Diagnostics Market - Russia
- 10.4.12.1. Russia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.4.12.2. Russia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.4.12.3. Russia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.4.12.4. Russia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.4.12.5. Russia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5. Microbiome Diagnostics Market - Asia Pacific
- 10.5.1. Asia Pacific: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.6. Microbiome Diagnostics Market - China
- 10.5.6.1. China: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.6.2. China.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.6.3. China: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.6.4. China: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.6.5. China: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.7. Microbiome Diagnostics Market - India
- 10.5.7.1. India: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.7.2. India.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.7.3. India: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.7.4. India: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.7.5. India: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.8. Microbiome Diagnostics Market - Japan
- 10.5.8.1. Japan: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.8.2. Japan.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.8.3. Japan: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.8.4. Japan: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.8.5. Japan: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.9. Microbiome Diagnostics Market - Malaysia
- 10.5.9.1. Malaysia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.9.2. Malaysia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.9.3. Malaysia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.9.4. Malaysia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.9.5. Malaysia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.10. Microbiome Diagnostics Market - Indonesia
- 10.5.10.1. Indonesia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.10.2. Indonesia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.10.3. Indonesia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.10.4. Indonesia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.10.5. Indonesia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.5.11. Microbiome Diagnostics Market - South Korea
- 10.5.11.1. South Korea: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.5.11.2. South Korea.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.5.11.3. South Korea: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.5.11.4. South Korea: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.5.11.5. South Korea: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.6. Microbiome Diagnostics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.6.6. Microbiome Diagnostics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.6.6.2. Saudi Arabia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.6.6.3. Saudi Arabia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.6.6.4. Saudi Arabia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.6.6.5. Saudi Arabia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.6.7. Microbiome Diagnostics Market - UAE
- 10.6.7.1. UAE: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.6.7.2. UAE.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.6.7.3. UAE: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.6.7.4. UAE: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.6.7.5. UAE: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.6.8. Microbiome Diagnostics Market - Israel
- 10.6.8.1. Israel: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.6.8.2. Israel.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.6.8.3. Israel: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.6.8.4. Israel: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.6.8.5. Israel: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.6.9. Microbiome Diagnostics Market - South Africa
- 10.6.9.1. South Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.6.9.2. South Africa.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.6.9.3. South Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.6.9.4. South Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.6.9.5. South Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.7. Microbiome Diagnostics Market - Latin America
- 10.7.1. Latin America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.7.2. Latin America.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.7.3. Latin America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.7.4. Latin America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.7.5. Latin America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.7.6. Microbiome Diagnostics Market - Mexico
- 10.7.6.1. Mexico: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.7.6.2. Mexico.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.7.6.3. Mexico: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.7.6.4. Mexico: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.7.6.5. Mexico: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.7.7. Microbiome Diagnostics Market - Brazil
- 10.7.7.1. Brazil: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.7.7.2. Brazil.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.7.7.3. Brazil: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.7.7.4. Brazil: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.7.7.5. Brazil: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
- 10.7.8. Microbiome Diagnostics Market - Argentina
- 10.7.8.1. Argentina: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
- 10.7.8.2. Argentina.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
- 10.7.8.3. Argentina: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
- 10.7.8.4. Argentina: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
- 10.7.8.5. Argentina: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. DNA Genotek
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Genetic Analysis AS
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Microba
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. 4D Pharma PLC
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. AOBiome Therapeutics
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Atlas Biomed
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. BioGaia
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. BIOHM Health
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Bione Ventures Private Limited
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. DayTwo
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Enterome
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Evvy
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Ferring Pharmaceuticals
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
- 12.14. Finch Therapeutics Group
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development
- 12.15. Flightpath Biosciences, Inc
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development
샘플 요청 목록